KensaGroup

What is KensaGroup?

KensaGroup is a venture capital and private equity firm that specializes in the commercialization of leading-edge platform discoveries from universities and corporate research laboratories into startup ventures. They are heavily focused on bridging the gap between academic intellectual property (IP) and technology commercialization.

With a proprietary process known as A2I™ (Academic-to-Industry), KensaGroup identifies, evaluates, and develops business strategies for promising intellectual property platforms, creating the scientific, institutional, and financial bridges necessary to move from initial discovery to market-ready products and services.

Since its inception in 2000, KensaGroup has reviewed over 3,000 technologies for commercialization potential. The firm's scientific specialization is primarily chemistry-centric, allowing them to have a broad portfolio that intersects a wide range of industries.

These include biotechnology, chemicals, materials, energy, medical devices, pharmaceuticals, financial services, agriculture, electronics, and automotive sectors. KensaGroup boasts a team with over 100 years of combined experience in early-stage commercialization, composed of C-level business managers, experienced financiers, and internationally recognized scientists.

This allows them to offer in-depth expertise and a comprehensive approach to IP commercialization, ensuring that the innovations they support are not only scientifically sound but also market-relevant. Their mission is centered on developing market-relevant, leading-edge intellectual property platforms via startup companies that they create, ensuring a successful transition from academic breakthroughs to commercial successes.

KensaGroup has a track record of working on a contract basis with corporate, academic, and government partners to position IP in a manner that maximizes value. The results of their work include successful partnerships, commercial products, and advancements in various technology sectors.